M
Marmar Vaseghi
Researcher at University of California, Los Angeles
Publications - 149
Citations - 5822
Marmar Vaseghi is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Ventricular tachycardia & Catheter ablation. The author has an hindex of 36, co-authored 129 publications receiving 4641 citations. Previous affiliations of Marmar Vaseghi include Center for Excellence in Education & Ronald Reagan UCLA Medical Center.
Papers
More filters
Journal ArticleDOI
Ventricular Tachycardia Ablation in the Elderly: An International Ventricular Tachycardia Center Collaborative Group Analysis.
Kairav Vakil,Santiago Garcia,Roderick Tung,Marmar Vaseghi,Usha B. Tedrow,Paolo Della Bella,David S. Frankel,Pasquale Vergara,Luigi Di Biase,Koichi Nagashima,Shiro Nakahara,Wendy S. Tzou,J. David Burkhardt,Timm Dickfeld,J. Peter Weiss,Jared Bunch,David J. Callans,Dhanunjaya Lakkireddy,Andrea Natale,William H. Sauer,William G. Stevenson,Francis E. Marchlinski,Kalyanam Shivkumar,Venkatakrishna N. Tholakanahalli +23 more
TL;DR: VT ablation in the elderly is feasible and reasonably safe with a modestly higher in-hospital and 1-year mortality, with similar rates of VT recurrence at 1 year compared with younger patients.
Journal ArticleDOI
Electrophysiological differences between the epicardium and the endocardium of the left atrium
Yoav Michowitz,Shiro Nakahara,Tara Bourke,Eric Buch,Marmar Vaseghi,Carlos De Diego,Isaac Wiener,and Aman Mahajan M.D.,Kalyanam Shivkumar +8 more
TL;DR: This study compared the electrophysiological properties and vulnerability to arrhythmia induction from these regions to compare the atrial endocardium compared to epicardium.
Journal ArticleDOI
Successful Ablation of an Epicardial Ventricular Tachycardia Using a Surgical Ablation Tool
TL;DR: A 62-year-old woman with ischemic cardiomyopathy (left ventricular ejection fraction, 15%) underwent HeartMate II (Thoratec, Inc, Pleasanton, CA) left ventricular assist device (LVAD) placement in January 2011 for cardiogenic shock.
Journal ArticleDOI
Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmias
Veronica Dusi,Veronica Dusi,Julie M. Sorg,Jeffrey Gornbein,Jean Gima,Jane Yanagawa,Jay M. Lee,Natalia Vecerek,Marmar Vaseghi,Jason S. Bradfield,Gaetano M. De Ferrari,Kalyanam Shivkumar,Olujimi A. Ajijola +12 more
TL;DR: In patients with SHD undergoing CSD LAVI predicts death/OHT, while AAs burden was unchanged after BCSD, while the need for atrial pacing increased, suggesting an impact of B CSD on sinus node chronotropism.
Journal ArticleDOI
Neuraxial modulation for ventricular arrhythmias: A new hope
TL;DR: SCS represents a novel strategy for neuraxial modulation and has been used safely for decades in the treatment of peripheral vascular disease, refractory angina, Raynaud’s disease, and neuropathic pain but many of the mechanisms behind the cardiac benefits of SCS are unclear.